生物
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019-20冠状病毒爆发
免疫学
病毒学
倍他科诺病毒
免疫
2019年冠状病毒病(COVID-19)
免疫系统
冠状病毒感染
大流行
疾病
爆发
医学
内科学
传染病(医学专业)
作者
Carly G.K. Ziegler,Vincent N. Miao,Anna H. Owings,Andrew W. Navia,Ying Tang,Joshua D. Bromley,Peter Lotfy,Meredith Sloan,Hannah Laird,Haley B. Williams,Micayla George,Riley S. Drake,Taylor Christian,Adam Parker,Campbell B. Sindel,Molly W. Burger,Yilianys Pride,Mohammad Hasan,George Abraham,Michal Šenitko
出处
期刊:Cell
[Cell Press]
日期:2021-07-23
卷期号:184 (18): 4713-4733.e22
被引量:296
标识
DOI:10.1016/j.cell.2021.07.023
摘要
SARS-CoV-2 infection can cause severe respiratory COVID-19. However, many individuals present with isolated upper respiratory symptoms, suggesting potential to constrain viral pathology to the nasopharynx. Which cells SARS-CoV-2 primarily targets and how infection influences the respiratory epithelium remains incompletely understood. We performed scRNA-seq on nasopharyngeal swabs from 58 healthy and COVID-19 participants. During COVID-19, we observe expansion of secretory, loss of ciliated, and epithelial cell repopulation via deuterosomal cell expansion. In mild and moderate COVID-19, epithelial cells express anti-viral/interferon-responsive genes, while cells in severe COVID-19 have muted anti-viral responses despite equivalent viral loads. SARS-CoV-2 RNA
科研通智能强力驱动
Strongly Powered by AbleSci AI